Speakers
Nicholas Agard, Scientist, Genentech
Methal Albarghouthi, Director, Analytical Sciences, AstraZeneca
Mr Philip Arlen, President And Chief Executive Officer, Precision Biologics Inc
Tudor Arvinte, President And Chief Executive Officer, Therapeomic Inc
Mr Rene Assenberg, Associate Director, Janssen Pharmaceutical
Sameer Awsare, Associate Executive Director, The Permanente Medical Group Inc
Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences
Caroline Barelle, Chief Executive Officer, Elasmogen
Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Dr Philip Beer, Physician Scientist And Precision Oncology Specialist, Sanger Institute
Mr Jannick Bendtsen, CEO, PipeBio ApS
Martin Bertschinger, Deputy Cell Sciences Director, Ichnos Sciences
María Lucía Bettati, Business Unit Director Gen Med, Amgen
Florian Bieber, Vice President Of Clinical Development And Drug Safety, Sandoz
Horst Bierau, Senior Scientific Advisor - Head CMC Science & Intelligence, Merck Serono
Ailsa Bosworth, National Patient Champion, National Rheumatoid Arthritis Society
Ms Kate Broderick, Senior Vice President, Research And Development, Inovio Pharmaceuticals
Kathryn Brown, Intermin Vice President for pharmacy, Kaiser Permanente
Patrick Bulau, Principal Scientist, Roche Pharma
Sara Carillo, Applications Development Team Leader, NIBRT
Samuele Cazzamalli, Group Head, Philochem
Dr Brian Champion, CSO, PsiOxus Therapeutics Ltd
Eleni Chantzoura, Team Leader – Immune Receptor Discovery, AgenTus Therapeutics
John Chappell, Application And Service Director Emea And Asia Pacific, Gyros Protein Technologies
Vijay Chudasama, Reader, UCL
Dr Sara Colombetti, Global Head Oncology Discovery Pharmacology, Roche Innovation Center Zurich
Dr James Crowe, Director, Vanderbilt Vaccine Center
Blake Dark, Commercial Medicines Director, NHS England
Dr John Delaney, Director, Research Technologies And Collaborations, Amgen Inc
Gundo Diedrich, Associate Director, MacroGenics
Achim Doerner, Principal Scientist, Merck KGaA
Helena Domingues, Patent Examiner, European Patent Office
Mr Ramana Doppalapudi, Director Of Chemistry, Avidity BioSciences
Roman Drai, RnD Director, Geropharm
Stefan Duebel, Director, Technical University of Braunschweig
Robert Duncombe, Medical Director, The Christie N.H.S. Foundation Trust
Pascal Egloff, Platform Leader, University of Zurich
David Falck, Assistant Professor, Leiden University Medical Center
Hanspeter Gerber, Interim CEO, CSO, 3T Biosciences
Bruno Gomes, Global Head Of Biomarkers Oncology, Roche
Ms Deya Gonzalez, Associate Professor, Swansea University
Victor Greiff, Associate Professor, Department Of Immunology, The University of Oslo
Dr Farshad Guirakhoo, CSO, Covaxx
Mr eric halioua, President & CEO, PDC*line pharma SA
Riz Haq, Assistant Professor, Harvard Medical School
Eliott Harfouche, Partner, Nodes Advisors
Katherine Harris, VP Discovery, Teneobio
Mr Oliver Hill, Vice President, Drug Discovery, Protein Engineering, Apogenix AG
Soraya Hölper, Lab Head Mass Spectrometry, Sanofi - Biologics Research
Thomas Huber, Head of Research, Almirall
Mr Gregor Hutter, Research Group Leader, University Hospital Basel
Ylenia Ingrasciotta, Senior Pharmacoepidemiologist, University of Messina
Ms Melita Irving, Group Leader T-Cell Engineering, University of Lausanne
Timothy Jenkins, H.C. Orsted Postdoctoral Fellow, Technical University of Denmark
Ms Jennifer Jung, Lab Head Mass Spectrometry, sanofi
Sophia Karagiannis, Professor Of Translational Cancer Immunology And Immunotherapy, King's College London
Dr Christian Klein, Dept Head, Roche Pharmaceutical Research and Early Development
Eva Kollar, Team Lead, Formulation Development, Biotechnology, Gedeon Richter PLC
Harald Kolmar, Head of department applied biochemistry, TU Darmstadt Biochemie
Jiri Kovarik, Research Investigator, NIBR
Dan Bach Kristensen, Principal Scientist, Symphogen
Hannah Kuchler, US Pharma and Biotech Correspondent, Financial Times
Russell Lamontagne, Chief Executive Officer, Boston Immune Technologies And Therapeutics
Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel
Andreas Hougaard Laustsen, Postdoctoral, Technical University of Denmark
Christophe Le Tourneau, Head Of Clinical Research, Department Of Medical Oncology, Curie Institute
John Lofblom, Professor in Combinatorial Protein Engineering, K.T.H. Royal Institute of Technology
Ms Angelica Loskog, Chief Executive Officer, Lokon Pharma
Mr Peter Lowe, Director, Biologics Generation And Optimization, Pierre Fabre
Heinz Lubenau, Chief Executive Officer, Vaximm Gmbh
Nanna Luneborg, Partner, Novo Ventures
Bernard Malliere, Head of laboratory, CEA
Julie Marechal-Jamil, Biosimilars Policy & Science, Medicines for Europe
Andrea Marschall, Postdoctoral, Brandeis University
Mr Shyam Masrani, Associate, Medicxi Ventures
Lamine Mbow, Senior Vice President - Head Of Nbe Discovery, Ichnos Sciences
Patrick Merkle, Researcher, Novartis
Christoph Merten, Professor, Laboratory for Biomedical Microfluidics, EPFL
Ali Mohamed, Vice President, CMC, Immatics Inc
Dario Neri, Co-Founder, Philogen; Department Of Chemistry And Applied Biosciences, Swiss Federal Institute of Technology Zurich
Sarfaraz Niazi, Adj. Professor of Pharmaceutical Sciences, University of Illinois
Cecil Nick, Vice President - Technical, Parexel
Simone Nicolardi, Senior Researcher, Leiden University Medical Center
Johan Nilvebrant, Researcher, K.T.H. Royal Institute of Technology
Professor Ahuva Nissim, Professor, William Harvey Research Institute
Mr Oliver Nussbaumer, VP, Immunology, GammaDelta Therapeutics
David O'Connell, Assistant Professor, School Of Biomolecular And Biomedical Science, University College Dublin
Benjamí Oller-Salvia, Assistant Professor, Ramon Llull University (URL)
Marc Pallardy, Professor and head of the Department of Toxicology, Universite Paris Sud
Dr Rajita Pappu, Senior Scientist, Genentech
Paul Parren, EVP, Lava Therapeutics
Martin Perry, Consultant Physician And Rheumatologist, Honorary Senior Clinical Lecturer, NHS Greater Glasgow & Clyde
Jutta Petschenka, Principal Scientist, Boehringer Ingelheim
Tanja Piller, Analytics Expert, Sanofi
Thomas Pillow, Senior Scientist, Genentech
Andreas Plueckthun, Professor Of Biochemistry, Director, Department Of Biochemistry, University of Zurich
Mr Tony Polverino, Executive Vice President Of Early Development And Chief Scientific Officer, Zymeworks Inc
Elke Prade, Scientist, Boehringer Ingelheim
Eva Rahman Kabir, Professor, Brac University
Sundar Ramanan, Vice President, Head, Global Regulatory Affairs, Biocon Pharmaceuticals
Matthew Raybould, PhD Student, University of Oxford
Isabell Remus, Head Biopharmaceuticals Europe, Sandoz
Nicoló Rigamonti, Project Leader And Biology Lead, Molecular Partners AG
Udo Roth, Laboratory Head MS, Sanofi Pasteur
Mark Samaan, Clinical Research Fellow, Guy’s and St Thomas N.H.S Foundation Trust
Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience
Karsten Sauer, VP, Repertoire Immune Medicines
Philip Schneider, Advisory Board Chair, Alliance for Safe Biologic Medicines
Maren Schubert, Postdoc, Technical University of Braunschweig
Chris Scott, Acting Director of the Patrick Johnston Centre for Cancer Research, Queen's University Belfast
Markus Seeger, Associate Professor, University of Zurich
Peter Senter, Vice President Of Chemistry, Seattle Genetics Inc
Armin Sepp, Scientific Leader And Gsk Associate Fellow, GlaxSmithKline
Dr Limin Shang, Director Of Pharmacology, Light Chain Bioscience - A brand of Novimmune SA
Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc
Arne Skerra, Professor - Biological Chemistry, TU Munich
Andreu Soldevila, Chief Executive Officer, Syna Therapeutics
Pietro Sormanni, Royal Society University Research Fellow, University of Cambridge
David Spring, Professor, University of Cambridge
Philipp Spycher, Psi Founder Fellow, Paul Scherrer Institut
Pawel Stocki, Reseach Director, Ossianix, Inc.
Peter Szijj, Phd Student, University College London
Greg Thurber, Assistant Professor Of Chemical Engineering, University of Michigan
Omid Vafa, Chief Business Officer, Teneobio
Mr Omid Vafa, Chief Business Officer, Teneobio
Dr Timo van den Berg, Professor and group leader, Sanquin Research
Marjolein Van Egmond, Professor Of Oncology And Inflammation, VU University Medical Center Amsterdam
Bernard Vanhove, COO, Xenothera
Mr Johannes Vom Berg, Group Leader, Institute Of Laboratory Animal Science, University of Zurich
Meenu Wadhwa, Section Leader For Cyotkines And Growth Factors Section, NIBSC
Mr Alain Wagner, Research Director, Centre National De La Recherche Scientifique
Sally Ward, Professor of Molecular Immunology and Director of Translational Immunology, University of Southampton
Yariv Wine, Senior Lecturer And Assistant Professor, Tel Aviv University
Sijme Zeilemaker, COO, Immunicum
Mr Markus Zettl, Director Immuno, Oncology, Pieris Pharmaceuticals
Stefan Zielonka, Associate Director, Protein Engineering And Antibody Technologies, Merck KGaA
Organiser
